BRCA1 and breast carcinoma: In the most advanced stage of development in breast cancer and as already mentioned earlier, the combination of veliparib with carboplatin-paclitaxel or temozolomide regimen in BRCA1/2-associated advanced breast cancer was demonstrated to be feasible but efficacy was uncertain [75].